NCT03058406已完成不适用
Special Use Investigation of HALAVEN (HAL03T) - Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 256
- 主要终点
- Number of Adverse Events (AEs) and Adverse Drug Reactions (ADRs)
研究概览
简要总结
The purpose of this study is to understand safety and efficacy in participants with soft tissue sarcomas.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants with soft tissue sarcoma who will receive eribulin mesylate per the approved indication in routine clinical practice
排除标准
- 未提供
研究组 & 干预措施
Eribulin mesylate
干预措施: Eribulin mesylate (Drug)
结局指标
主要结局
Number of Adverse Events (AEs) and Adverse Drug Reactions (ADRs)
时间窗: up to 2 years
次要结局
- Survival Rate at Year 2(up to 2 years)
研究者
相似试验
已完成
1 期
Periocular Rejuvenation by Topical Hyaluronic Acid Nano ParticlesTear Trough Eyelid DeformityDark EyelidsWrinkleNCT05742399Alexandria University30
已完成
3 期
An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in MelanomaMelanomaNCT01368276BioVex Limited31
已完成
不适用
HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart ValveMitral Valve DiseaseDamaged Mitral ValveMalfunctioning Mitral Heart ValveMitral Valve ReplacementNCT02097420Abbott Medical Devices23
已完成
不适用
Effectiveness Trial for Evaluating IAHA for PFPSPatellofemoral Pain SyndromeNCT01811654NYU Langone Health30
已完成
3 期
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisEnd Stage Renal DiseaseHemodialysisVascular AccessRenal FailureNCT03183245Humacyte, Inc.242